Avet Pharma Announces Executive Leadership Changes

East Brunswick, NJ, April 18, 2018. Avet Pharmaceuticals Inc., an East Brunswick-based specialty generic pharmaceutical company, today announced that industry veteran William S. Marth has joined the Company as President and Chief Executive Officer, North America and Europe, of the Company’s parent, Avet Pharma Holdings Inc. Mr. Marth also will be appointed as a member of the Company’s Board of Directors and a member of the Board of Directors for two of the Company’s affiliates, Marcan Pharmaceuticals (Canada) and Emcure Pharma UK Limited (Europe). Avet also today announced that John W. Denman has joined as the President of Avet Pharmaceuticals Inc.

Download Press Release